After four long years, Dr. Brian Hooker’s reanalysis of the CDC’s MMR-autism data from the original Destefano et al. 2004 Pediatrics paper has been republished in the Winter 2018 Edition of the Journal of American Physicians and Surgeons. The data, when properly analyzed, using the CDC’s own study protocol, show a strong, statistically significant relationship between the timing of the first MMR vaccine and autism, specifically in African American males. In addition, a relationship also exists in the timing of the MMR vaccine and those individuals who were diagnosed with autism without mental retardation. These relationships call into question the conclusion of the original Destefano et al. 2004 paper which dismissed a connection between the MMR vaccine and autism.
It was four years ago, August 2014, that a senior CDC scientist—Dr. William Thompson–claimed whistleblower protection by claiming that the CDC had committed fraud by hiding and manipulating data that showed the MMR vaccine was associated with a higher risk of autism. According to the CDC, we are currently suffering through an exponential increase in autism since the 1970s. In 1970, the autism rate was 1 in 10,000. In 2018, the rate of autism epidemically increased to 1 in 59 children. That is a 169-fold increase in autism in U.S. children over nearly 50 years! You would think a senior CDC scientist who claims malfeasance at the CDC is responsible for the rapid rise in autism would immediately trigger Congressional investigations to find out the truth. However, our dysfunctional Congress would prove you wrong.
I just got a video of the child I mentioned in my last post. He has severe autism. He is the son of a respected board certified physician who has declared with 100% certainty that his beloved son was vaccine injured. He, like any parent, would move heaven and earth for his child. He has given permission to share. Two days ago the child had his fourth ozone treatment in our office. As usual, we had to restrain him. But strange, the high pitched cries were absent. We had already been told that a few days before, in his sleep, he was actually talking sentences, though the parents could not make out the words. This was new. He has also been taking supplements to reduce his high levels of aluminum documented by lab in his system. The video you see here is also showing quite new behavior. In the doctor’s words, “He was actually processing how to ride the scooter. It was the first time I’ve ever seen that in him. In the past he’d get frustrated. This time he moved the scooter backwards and time he accomplished riding it. He was smiling and was happy, also a first. He was playful. He was smiling. This has never happened before. A few days ago he was talking in his sleep, he was engaging in a conversation while sleeping. This was also a first. I am just to impressed and thankful to God, and to you and Dr. Su and your staff. You care.” I told the doctor that a case like this means more to us that most any other case. This child still has a life to live.
Dr. Zhibin Yao of Sun Yat-sen University (a Top 10 university in China) is not a household name in the American autism community, but perhaps he should be. Not only is he American-educated (University of Pittsburgh) and the author of 33 peer-reviewed studies, but he's also the lead author of two of the most important biological studies ever done analyzing how, exactly, a vaccine can cause autism. Dr. Yao conducted a thorough study of the Hepatitis B vaccine's impact on the brains of mice, and did so versus a control group of mice who received a saline placebo. This is a "gold standard" animal study that you would typically do BEFORE a drug was introduced to the human population. In a world where vaccines were treated like other prescription drugs, Dr. Yao's study would have sent up a giant red flag about the neurotoxicity of the Hepatitis B vaccine. Of course, that didn't happen, and this is the first time you've probably ever heard of this study. Dr. Yao and his colleagues open with a statement that should make every American parent shudder: "The hepatitis B vaccine (HBV) is administered to more than 70% of neonates worldwide. Whether this neonatal vaccination affects brain development is unknown." Even more concerning, is the concluding statement they wrote: “This work reveals for the first time that early HBV vaccination induces impairments in behavior and hippocampal neurogenesis. This work provides innovative data supporting the long suspected potential association of HBV with certain neuropsychiatric disorders such as autism and multiple sclerosis.”
Rates of autism spectrum disorder (ASD) continue to soar worldwide, with average prevalence estimated to be around 1.5% in developed countries. This estimate appears to be spot-on for Canada, which reported in March 2018 that autism (as of 2015) affected 1 in 66 children and youth (1.52%). These numbers place Canada among the “top ten” for autism among North American, European and Asian countries. ASD prevalence in 2015 varied among the seven regions, with the highest prevalence noted in the three provinces of Newfoundland and Labrador (1 in 57), Prince Edward Island (1 in 59) and Quebec (1 in 65). In comparison, prevalence was substantially lower in the Yukon territory (1 in 125). What might explain the variation in ASD prevalence within Canada’s borders? The NASS report does not offer any comments. However, an observant health practitioner in British Columbia has noticed a compelling parallel: autism prevalence is highest in the Canadian provinces that also have the highest vaccination coverage.
It is both astonishing and insulting that, nearly three decades in, federal agencies and public health experts persist in denying and refusing to tackle our nation’s staggering autism epidemic. With typical dismissiveness (and a straight face), one group of pediatric researchers recently had the temerity to put the word “epidemic” in quotes while endorsing the charade that the rising prevalence of autism is attributable to broader diagnostic criteria, increased awareness and “the inclusion of milder neurodevelopmental differences bordering on normality.” The government’s own surveys—as well as parents, school systems and municipal budgets—tell an entirely different story, however. Autism spectrum disorders (ASDs) began skyrocketing in the late 1980s, concurrent with a massive expansion of the childhood vaccine schedule and a corresponding increase in children’s exposure to neurotoxic vaccine ingredients such as mercury and aluminum. Over the years, many of the CDC’s bulletins about ASD prevalence have placidly reported that “ASDs are more common than was believed previously.” However, the continued dramatic rise in ASD prevalence and autism’s heavy burden on individuals, families, schools and wider society call for a far greater sense of urgency. Autism must be recognized as a national crisis. As of this writing (April 2018), the CDC is due to release its latest ADDM surveillance numbers. Will our federal health agencies continue to downplay the numbers’ significance, as they have done each time the data show a rise in ASD prevalence? Or will they finally sound an alarm and make it a top priority to find out what is causing this epidemic in our children? No one—and not least the agencies that are supposed to be looking out for children’s best interests—can afford to be complacent any longer about this unjustifiably neglected public health emergency.
A particularly large amount of ink has been spilled to discredit—nay, stomp out—the inconvenient notion that vaccines might have something to do with autism spectrum disorder (ASD), which now affects 1 in 36 children in the U.S. Despite extensive high-level scientific fraud at the Centers for Disease Control and Prevention (CDC) to suppress evidence of a vaccine-autism link, the CDC has not been able to hide over 80 independent studies that connect the dots between the vaccine preservative thimerosal and autism. Other studies have pointed to additional vaccine-related culprits that may be contributing to ASD, including aluminum—used in a very high proportion of infant vaccines and recently reported in pathologically significant levels in the brains of individuals diagnosed with autism. The latest example is on display in a 2018 study published in JAMA Pediatrics titled “Vaccination patterns in children after autism spectrum disorder diagnosis and in their younger siblings.” The nine studies that the JAMA Pediatrics authors cite to “show” that autism is unrelated to vaccines are wholly inadequate to make any such assertion. Two of the studies are merely review articles published in 2001 and 2002, both written by the same corrupt CDC author who provides no original data on the subject. An additional paper headed up by the same author in 2004 has been shown to be fraudulent, as the five authors purportedly conspired to withhold measles-mumps-rubella (MMR) and autism data that implicated the MMR vaccine for specific subpopulations of children with ASD. Yet another of the papers cited by the JAMA Pediatrics authors, a 2003 paper involving thimerosal-containing vaccines in Denmark, was thoroughly debunked by a later CDC study that showed a reduction in ASD prevalence in Denmark after the removal of thimerosal from vaccines in 1992. The nine flimsy, flawed and out-and-out fraudulent studies that the JAMA Pediatrics authors cite as a basis for their contention that vaccines don’t cause autism focus only on thimerosal in vaccines and the MMR vaccine. Setting aside the issue of these studies’ poor quality, one has to ask, “What about the rest of the vaccine schedule?” It is essentially unstudied! In fact, in 2011, the Institute of Medicine stated that there were insufficient data to judge whether the diphtheria-tetanus-acellular pertussis (DTaP) vaccine—one of those included in the 2018 JAMA Pediatrics study—caused autism. The Institute acknowledged that there simply hadn’t been proper studies done by the CDC or other entities charged with vaccine safety in the U.S.
Due largely to increased vaccination demands and other toxic food and environment factors, the horror of life-long autism ruining families is constantly increasing. With mainstream medicine’s failure to even moderately improve those children’s quality of life, desperate parents of autistic children are finding that medical marijuana can sometimes offer amazing results, and mainstream media is starting to take note. On the last week of February 2018, Newsweek ran an article titled, “Is Marijuana the World’s Most Effective Treatment for Autism?” The question alone was controversial.
The incidence of childhood cancers has been steadily rising for several decades, to such an extent that cancers in young people now have their very own day in the limelight: International Childhood Cancer Day (February 15). For American children ages one through 14, cancer is the top disease-related cause of death, second only to accidents among all causes of childhood mortality. Leukemia and malignancies of the central nervous system are the most common types of childhood cancers. A recent opinion piece in The Hill points out that autism spectrum disorders (ASDs) have increased in lockstep with pediatric cancers. One in thirty-six (2.76%) children aged three-17 had an ASD diagnosis as of 2016, compared to one in 10,000 children in the 1970s. The parallel rise in the two conditions is not a fluke—environmental toxins are widely known to “initiate or aggravate various neurological disorders [and] carcinomas.” Although the National Cancer Institute (NCI) views environmental causes of childhood cancers as “difficult to identify,” one route of exposure to heavy metals and other toxic substances that begins prenatally and continues through adolescence is sitting in plain sight: the bloated U.S. vaccine schedule.
At least one in six American children (roughly 17%) has a diagnosed developmental disability. No matter which once-rare disorder one considers—learning disabilities, autism spectrum disorder (ASD), attention deficit/hyperactivity disorder (ADHD), tics, obsessive-compulsive disorder (OCD) or emotional disturbances—each has witnessed a dramatic escalation over the past several decades. A systematic literature review recently published in Acta Neurobiologiae Experimentalis contends that these trends are at crisis proportions. The crisis is spiraling out of control, with society-wide impacts on services, institutions, families and, especially, boys. There are at least two boys for every girl with a neurodevelopmental disorder. For ASD and ADHD, the male-to-female ratio is roughly four and five to one, respectively. Genetics cannot explain this consistent sex-specific pattern. What can explain it is children’s vastly increased exposure to and bioaccumulation of chemical neurotoxins at the same time that the explosion in neurodevelopmental disorders has unfolded. In fact, the skewed sex ratio is, in and of itself, a vital clue that can help pinpoint major causes of neurodevelopmental disorders. Unfortunately, research funding priorities in the U.S. are highly distorted, as the field of ASD research illustrates. In 2013, the federal government awarded more than 38 times as much funding ($291 million) to ASD researchers studying genetics as to those studying ASD’s environmental aspects ($7.5 million)—even though genetics “only addresses at best about 20% of the ASD population.”